sapacitabine
Showing 1 - 5 of 5
Breast Cancer Trial in Boston, Cambridge (Sapacitabine, Olaparib)
Active, not recruiting
- Breast Cancer
- Sapacitabine
- Olaparib
-
Boston, Massachusetts
- +1 more
May 2, 2022
Leukemias, MDS Trial in Houston (sapacitabine)
Completed
- Leukemias
- Myelodysplastic Syndromes
- sapacitabine
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Dec 7, 2021
NSCLC Trial in Chicago, Hershey (sapacitabine)
Terminated
- Non-small Cell Lung Cancer
- sapacitabine
-
Chicago, Illinois
- +1 more
Dec 7, 2021
Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford, Chicago, Houston (Sapacitabine)
Terminated
- Cutaneous T-cell Lymphoma (CTCL)
- Sapacitabine
-
Stanford, California
- +2 more
Dec 7, 2021
Leukemia Trial in Houston (Cyclophosphamide, Rituximab, Sapacitabine)
Terminated
- Leukemia
- Cyclophosphamide
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 15, 2019